146 related articles for article (PubMed ID: 37066598)
1. Second-line treatment of pediatric patients with relapsed rhabdomyosarcoma adapted to initial risk stratification: Data of the European Soft Tissue Sarcoma Registry (SoTiSaR).
Heinz AT; Ebinger M; Schönstein A; Fuchs J; Timmermann B; Seitz G; Vokuhl C; Münter MW; Pajtler KW; Stegmaier S; von Kalle T; Kratz CP; Rößler J; Ljungman G; Klingebiel T; Koscielniak E; Sparber-Sauer M;
Pediatr Blood Cancer; 2023 Jul; 70(7):e30363. PubMed ID: 37066598
[TBL] [Abstract][Full Text] [Related]
2. Significance of fusion status, Oberlin risk factors, local and maintenance treatment in pediatric and adolescent patients with metastatic rhabdomyosarcoma: Data of the European Soft Tissue Sarcoma Registry SoTiSaR.
Heinz AT; Schönstein A; Ebinger M; Fuchs J; Timmermann B; Seitz G; Vokuhl C; Münter M; Pajtler KW; Stegmaier S; von Kalle T; Kratz CP; Ljungman G; Juntti H; Klingebiel T; Koscielniak E; Sparber-Sauer M;
Pediatr Blood Cancer; 2024 Jan; 71(1):e30707. PubMed ID: 37814424
[TBL] [Abstract][Full Text] [Related]
3. Long-term results from the multicentric European randomized phase 3 trial CWS/RMS-96 for localized high-risk soft tissue sarcoma in children, adolescents, and young adults.
Sparber-Sauer M; Ferrari A; Kosztyla D; Ladenstein R; Cecchetto G; Kazanowska B; Scarzello G; Ljungman G; Milano GM; Niggli F; Alaggio R; Vokuhl C; Casanova M; Klingebiel T; Zin A; Koscielniak E; Bisogno G
Pediatr Blood Cancer; 2022 Sep; 69(9):e29691. PubMed ID: 35441463
[TBL] [Abstract][Full Text] [Related]
4. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
5. Serial intense chemotherapy combining topotecan, etoposide, carboplatin and cyclophosphamide (TECC) followed by autologous hematopoietic stem cell support in patients with high risk soft tissue sarcoma (STS).
Bernbeck B; Bahci S; Meisel R; Troeger A; Schönberger S; Laws HJ; Kramm C; Wessalowski R; Koscielniak E; Dilloo D; Göbel U
Klin Padiatr; 2007; 219(6):318-22. PubMed ID: 18050041
[TBL] [Abstract][Full Text] [Related]
6. Treatment and outcome of patients with localized intrathoracic and chest wall rhabdomyosarcoma: a report of the Cooperative Weichteilsarkom Studiengruppe (CWS).
Fuchs J; Urla C; Sparber-Sauer M; Schuck A; Leuschner I; Klingebiel T; Blumenstock G; Seitz G; Koscielniak E
J Cancer Res Clin Oncol; 2018 May; 144(5):925-934. PubMed ID: 29464349
[TBL] [Abstract][Full Text] [Related]
7. Topotecan/carboplatin regimen for refractory/recurrent rhabdomyosarcoma in children: Report from the AIEOP Soft Tissue Sarcoma Committee.
Compostella A; Affinita MC; Casanova M; Milano GM; Scagnellato A; Dall'Igna P; Chiaravalli S; Pierobon M; Manzitti C; Zanetti I; Schiavetti A; Sorbara S; Mura RM; Ruggiero A; Ferrari A; Bisogno G
Tumori; 2019 Apr; 105(2):138-143. PubMed ID: 30131003
[TBL] [Abstract][Full Text] [Related]
8. Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults.
Dantonello TM; Int-Veen C; Harms D; Leuschner I; Schmidt BF; Herbst M; Juergens H; Scheel-Walter HG; Bielack SS; Klingebiel T; Dickerhoff R; Kirsch S; Brecht I; Schmelzle R; Greulich M; Gadner H; Greiner J; Marky I; Treuner J; Koscielniak E
J Clin Oncol; 2009 Mar; 27(9):1446-55. PubMed ID: 19224858
[TBL] [Abstract][Full Text] [Related]
9. Treatment of children with relapsed soft tissue sarcoma: report of the German CESS/CWS REZ 91 trial.
Klingebiel T; Pertl U; Hess CF; Jürgens H; Koscielniak E; Pötter R; van Heek-Romanowski R; Rossi R; Schött C; Spaar HJ; Willnow U; Treuner J
Med Pediatr Oncol; 1998 May; 30(5):269-75. PubMed ID: 9544222
[TBL] [Abstract][Full Text] [Related]
10. Epithelioid sarcoma in children, adolescents, and young adults: Localized, primary metastatic and relapsed disease. Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
Sparber-Sauer M; Koscielniak E; Vokuhl C; Seitz G; Hallmen E; von Kalle T; Scheer M; Münter M; Bielack SS; Ladenstein R; Fuchs J; Klingebiel T;
Pediatr Blood Cancer; 2019 Sep; 66(9):e27879. PubMed ID: 31215116
[TBL] [Abstract][Full Text] [Related]
11. Rhabdomyosarcoma diagnosed in the first year of life: Localized, metastatic, and relapsed disease. Outcome data from five trials and one registry of the Cooperative Weichteilsarkom Studiengruppe (CWS).
Sparber-Sauer M; Stegmaier S; Vokuhl C; Seitz G; von Kalle T; Scheer M; Münter M; Bielack SS; Weclawek-Tompol J; Ladenstein R; Niggli F; Ljungman G; Fuchs J; Hettmer S; Koscielniak E; Klingebiel T;
Pediatr Blood Cancer; 2019 Jun; 66(6):e27652. PubMed ID: 30762282
[TBL] [Abstract][Full Text] [Related]
12. Outcome of extracranial malignant rhabdoid tumours in children registered in the European Paediatric Soft Tissue Sarcoma Study Group Non-Rhabdomyosarcoma Soft Tissue Sarcoma 2005 Study-EpSSG NRSTS 2005.
Brennan B; De Salvo GL; Orbach D; De Paoli A; Kelsey A; Mudry P; Francotte N; Van Noesel M; Bisogno G; Casanova M; Ferrari A
Eur J Cancer; 2016 Jun; 60():69-82. PubMed ID: 27082136
[TBL] [Abstract][Full Text] [Related]
13. Carboplatin in the treatment of Ewing sarcoma: Results of the first Brazilian collaborative study group for Ewing sarcoma family tumors-EWING1.
Brunetto AL; Castillo LA; Petrilli AS; Macedo CD; Boldrini E; Costa C; Almeida MT; Kirst D; Rodriguez-Galindo C; Pereira WV; Watanabe FM; Pizza M; Benites E; Morais V; Gadelha A; Nakasato A; Abujamra AL; Gregianin LJ;
Pediatr Blood Cancer; 2015 Oct; 62(10):1747-53. PubMed ID: 25917418
[TBL] [Abstract][Full Text] [Related]
14. Progress in the diagnosis and treatment of rhabdomyosarcoma and related soft tissue sarcomas.
Ruymann FB; Grovas AC
Cancer Invest; 2000; 18(3):223-41. PubMed ID: 10754991
[TBL] [Abstract][Full Text] [Related]
15. Nonmetastatic Rhabdomyosarcoma in Children and Adolescents: Overall Results of the European Pediatric Soft Tissue Sarcoma Study Group RMS2005 Study.
Bisogno G; Minard-Colin V; Zanetti I; Ferrari A; Gallego S; Dávila Fajardo R; Mandeville H; Kelsey A; Alaggio R; Orbach D; Terwisscha van Scheltinga S; Guillén Burrieza G; Ben-Arush M; Glosli H; Mudry P; Ferman S; Devalck C; Defachelles AS; Merks JHM; Jenney M
J Clin Oncol; 2023 May; 41(13):2342-2349. PubMed ID: 36848614
[No Abstract] [Full Text] [Related]
16. Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second-line chemotherapy.
Winter S; Fasola S; Brisse H; Mosseri V; Orbach D
Pediatr Blood Cancer; 2015 Nov; 62(11):1935-41. PubMed ID: 26150380
[TBL] [Abstract][Full Text] [Related]
17. ICE Regimen for Relapsed/Refractory Bone and Soft Tissue Sarcomas in Children.
Aydin B; Akyuz C; Varan A; Yalcin B; Kurucu N; Kutluk T
Rev Recent Clin Trials; 2018; 13(2):126-131. PubMed ID: 29366426
[TBL] [Abstract][Full Text] [Related]
18. Alveolar soft-part sarcoma: Primary metastatic disease and metastatic relapse occurring during long-term follow-up: Treatment results of four Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
Sparber-Sauer M; Seitz G; von Kalle T; Vokuhl C; Scheer M; Münter M; Bielack SS; Kazanowska B; Ladenstein R; Niggli F; Klingebiel T; Fuchs J; Koscielniak E;
Pediatr Blood Cancer; 2018 Dec; 65(12):e27405. PubMed ID: 30124238
[TBL] [Abstract][Full Text] [Related]
19. A report on second neo-plasms in seven children with solid tumors.
Hu H; Zhang W; Li J; Li F; Li R; Liu Z; Huang D
Ann Ital Chir; 2022; 92():331-338. PubMed ID: 36052474
[TBL] [Abstract][Full Text] [Related]
20. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.
Raney RB; Anderson JR; Barr FG; Donaldson SS; Pappo AS; Qualman SJ; Wiener ES; Maurer HM; Crist WM
J Pediatr Hematol Oncol; 2001 May; 23(4):215-20. PubMed ID: 11846299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
